Table 2.
Outcomes
| Patients, n (%) | Events, n (%) | |
|---|---|---|
| Hospitalization for infection | 80 (35) | 158 (100) |
| Respiratory | 52 (23) | 77 (49) |
| Urinary | 15 (7) | 33 (21) |
| Dermatological | 2 (0.9) | 4 (3) |
| Bacteriemia | 12 (5) | 17 (11) |
| Ear-nose-throat | 9 (4) | 11 (7) |
| Gastrointestinal | 8 (3) | 8 (5) |
| Eyes | 0 (0) | 0 (0) |
| Other | 3 (1) | 3 (2) |
| E causa ignota | 6 (3) | 8 (5) |
| Malignancy | 23 (10) | 37 (100) |
| Nonmelanoma skin malignancies | 14 (6) | 26 (70) |
| Solid malignanciesa | 10 (4) | 11 (30) |
| Relapse | 91 (40) | 164 (100) |
| Major relapse | 53 (23) | 102 (62) |
| Minor relapse | 38 (17) | 62 (38) |
| Major cardiovascular event | 18 (8) | 18 (100) |
| Myocardial infarction | 10 (4) | 10 (4) |
| Cerebral infarction | 3 (1) | 3 (1) |
| Cerebral hemorrhage | 2 (1) | 2 (1) |
| Amputation | 3 (1) | 3 (1) |
| End-stage renal disease | 16 (7) | 16 (7) |
Outcomes in number and percentages of the total number of patients and events.
a
Solid malignancies include one melanoma.